Used in pharmaceutical research as a key intermediate in the synthesis of antiviral agents, particularly in the development of adamantane-based drugs targeting influenza and other viral infections. Its structure supports enhanced binding to viral proteins, improving drug efficacy. Also investigated for use in central nervous system agents due to its ability to cross the blood-brain barrier. Employed in medicinal chemistry for optimizing pharmacokinetic properties such as stability and bioavailability.